(lp0
S'Catalyst Pharmaceuticals  Jumps: Stock Gains 18.2% Yahoo Finance - 19 hours ago Catalyst Pharmaceuticals, Inc. CPRX was a big mover last session, as its shares rose over 18% on the day. The move came on solid volume too with far more shares changing hands than in a normal session.'
p1
aS'Catalyst Pharmaceuticals Inc.  Pops on Earnings StockNewsUnion - Mar 27, 2017 Coral Gables, FL-based Catalyst Pharmaceuticals Inc.  shares had been struggling to stay at a price above $1.20 between the end of October, 2016 and March 14, 2017.How Does Catalyst Pharmaceuticals, Inc.  Stack Up Right Now? - StockNewsJournalCatalyst Pharmaceuticals, Inc.  shows weekly volitility of 12.11% - The Newburgh Press'
p2
aS'Catalyst Pharmaceuticals and ZIOPHARM Oncology Bounce Up On FDA Phase News Yahoo Finance - 23 hours ago Catalyst Pharmaceuticals began liftoff as its stock price rose 18.24 % to close at $2.01 on Monday. The stock traded between $2.065 and $1.63 on volume of 4,485,126 shares traded.Catalyst Pharmaceuticals, Inc.  Is Rising But Watch The Charts And Be ... - USA Commerce Daily'
p3
aS'Catalyst Pharma shares jump 22% premarket on news of positive trial results ... MarketWatch - Mar 15, 2017 Shares of Catalyst Pharmaceuticals Inc. CPRX, +1.99% jumped 22% in premarket trade Wednesday, after the biotech reported positive data from a trial of a treatment for a form of myasthenia gravis, a rare neuromuscular disease, for which there is ...Catalyst Pharma positive trial data of a treatment for a rare neuromuscular ... - Proactive Investors USA & Canada'
p4
aS"Lookout for Price Target? American Outdoor Brands Corporation , Catalyst ... StockNewsJournal - Mar 27, 2017 Catalyst Pharmaceuticals, Inc. , maintained return on investment for the last twelve months at -37.54, higher than what Reuters data shows regarding industry's average."
p5
aS"Financials of Aurinia Pharmaceuticals and Catalyst Pharmaceuticals are Getting ... Yahoo Finance - Mar 21, 2017 After hours trading showed a continued rise in the company's stock price. Catalyst Pharmaceuticals is a biopharmaceutical company that is currently focused on the development of innovative treatments dealing with rare neuromuscular and neurological&nbsp;..."
p6
aS'Catalyst Pharma  Focused on US Approval for Firdapse Yahoo Finance - Mar 23, 2017 Catalyst has in-licensed rights to Firdapse from BioMarin Pharmaceutical Inc. BMRN for the development and commercialization of the product in the U.S.HC Wainwright Reiterates Buy Rating for Catalyst Pharmaceuticals Inc  - BNB Daily Catalyst Pharmaceuticals Inc  Upgraded to Buy at Zacks Investment Research - The Cerbat Gem'
p7
aS'Revenue Approximations Analysis: Catalyst Pharmaceuticals, Inc. , Live ... StockNewsJournal - Mar 22, 2017 ROI deals with the invested cash in the company and the return the investor realize on that money based on the net profit of the business.'
p8
aS'Catalyst Pharma : What???s in Store in Q4 Earnings? Yahoo Finance - Mar 7, 2017 Catalyst Pharmaceuticals, Inc. CPRX is expected to report fourth-quarter 2016 results this month. Last quarter, the company recorded a positive earnings surprise of 16.67%.Catalyst Pharmaceutical Partners, Inc.  Broker Price Targets For The ... - Fiscal Standard'
p9
aS'Analysts Showing Optimistic Trends For Catalyst Pharmaceuticals, Inc.  News Oracle - 16 hours ago Catalyst Pharmaceuticals, Inc.  will report its next earnings on May 8 - May 12 . The company reported the earnings of $-0.05/Share in the last quarter where the estimated EPS by analysts was $-0.07/share.'
p10
a.